03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Letocan 50mg : | |
Type | Medicine Pending |
Originator | Cancidas 50mg |
Agent | Lebiran |
Distributor | Lebiran |
Laboratory | CinnaGen |
Manufacturer | CinnaGen Co |
Manufacturing Type | G |
Origin | Iran |
ATC | J02AX04 |
Letocan 50mg :
Letocan 50mg :
Letocan 50mg :
Letocan 50mg :
Letocan 50mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal distension | Uncommon |
Abdominal pain | Uncommon |
Abdominal pain upper | Uncommon |
Activated partial thromboplastin time prolonged | Uncommon |
Acute kidney injury | Uncommon |
Adult respiratory distress syndrome | Not known |
ALT increased | Common |
Anaemia | Uncommon |
Anaphylaxis | Not known |
Anorexia | Uncommon |
Anxiety | Uncommon |
Arrhythmia | Uncommon |
Arthralgia (Pain joint) (Joint ache) | Common |
Ascites | Uncommon |
AST increased | Common |
Atrial fibrillation | Uncommon |
Back pain | Uncommon |
Bilirubin conjugated increased | Common |
Blood albumin decreased | Common |
Blood alkaline phosphatase increased | Common |
Blood bicarbonate decreased | Uncommon |
Blood bilirubin increased | Common |
Blood calcium decreased | Uncommon |
Blood calcium increased | Uncommon |
Blood chloride decreased | Uncommon |
Blood chloride increased | Uncommon |
Blood creatinine increased | Uncommon |
Blood glucose increased | Common |
Blood magnesium decreased | Uncommon |
Blood phosphorus decreased | Common |
Blood phosphorus increased | Common |
Blood potassium decreased | Common |
Blood potassium increased | Uncommon |
Blood pressure increased | Uncommon |
Blood sodium decreased | Uncommon |
Blood sodium increased | Uncommon |
Blood urea increased | Uncommon |
Blood uric acid decreased | Uncommon |
Blood urine present | Uncommon |
Bone pain | Uncommon |
Breath sounds abnormal | Uncommon |
Bronchospasm | Uncommon |
Carbon dioxide decreased | Uncommon |
Catheter site pain | Common |
Chest discomfort | Uncommon |
Chest pain | Uncommon |
Chills | Common |
Cholestasis | Uncommon |
Coagulopathy | Uncommon |
Congestive heart failure | Uncommon |
Constipation | Uncommon |
Cough | Uncommon |
Dermatitis allergic | Uncommon |
Diarrhoea (Diarrhea) | Common |
Disorientation | Uncommon |
Dizziness | Uncommon |
Dry mouth (Xerostomia) | Uncommon |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Uncommon |
Dyspepsia | Uncommon |
Dysphagia | Uncommon |
Dyspnoea (dyspnea) | Common |
Dyspnoea paroxysmal nocturnal | Uncommon |
Electrolyte imbalance | Uncommon |
Eosinophil count increased | Common |
Erythema | Common |
Erythema multiforme | Uncommon |
Eyelid oedema | Uncommon |
Face oedema | Uncommon |
Fatigue | Uncommon |
Feeling cold | Uncommon |
Feeling of body temperature change | Uncommon |
Fever | Very Common |
Flatulence | Uncommon |
Fluid overload | Uncommon |
Flushing | Common |
Gamma-GT increased | Uncommon |
Haematocrit decreased | Common |
Haemoglobin decreased | Common |
Headache | Common |
Hepatic enzyme increased | Common |
Hepatic function abnormal | Uncommon |
Hepatomegaly | Uncommon |
Hepatotoxicity (liver toxicity) | Uncommon |
Hot flush | Uncommon |
Hyperbilirubinaemia | Uncommon |
Hypercalcaemia | Not known |
Hyperglycaemia | Uncommon |
Hyperhidrosis | Common |
Hypersensitivity reactions | Common |
Hypertension | Uncommon |
Hypocalcaemia | Uncommon |
Hypoesthesia | Uncommon |
Hypokalaemia | Common |
Hypomagnesaemia | Common |
Hypotension | Common |
Hypoxia | Uncommon |
Immunosuppressant drug level increased | Uncommon |
Induration | Uncommon |
Infusion site erythema | Uncommon |
Infusion site extravasation | Uncommon |
Infusion site induration | Uncommon |
Infusion site irritation | Uncommon |
Infusion site pain | Uncommon |
Infusion site phlebitis | Uncommon |
Infusion site pruritus | Common |
Infusion site rash | Uncommon |
Infusion site swelling | Uncommon |
Infusion site urticaria | Uncommon |
Injection site erythema | Uncommon |
Injection site oedema | Uncommon |
Injection site pain | Uncommon |
Injection site phlebitis | Uncommon |
Injection site swelling | Uncommon |
INR increased | Uncommon |
Insomnia | Uncommon |
Jaundice | Uncommon |
Lacrimation increased (Epiphora) | Uncommon |
Leucopenia (Leukopenia) | Uncommon |
Leukocyte count decreased (White blood cell count decreased) | Common |
Leukocyturia | Uncommon |
Liver disorder | Uncommon |
Lung infiltration (pulmonary infiltration) | Not known |
Lymphocyte count decreased | Uncommon |
Maculopapular rash | Uncommon |
Malaise | Uncommon |
Metabolic acidosis | Uncommon |
Muscle weakness | Uncommon |
Myalgia | Uncommon |
Nasal congestion | Uncommon |
Nausea | Common |
Neutrophil count decreased | Uncommon |
Ocular icterus | Uncommon |
Oedema | Uncommon |
Oedema peripheral | Uncommon |
Pain | Uncommon |
Pain in extremity (Pain in limb) | Uncommon |
Palpitations | Uncommon |
Paraesthesia (paresthesia) | Uncommon |
pH urine increased | Uncommon |
Pharyngolaryngeal pain | Uncommon |
Phlebitis | Common |
Platelet count decreased (Thrombocyte count decreased) | Uncommon |
Platelet count increased | Uncommon |
Protein total decreased | Uncommon |
Protein urine present | Uncommon |
Prothrombin time prolonged | Uncommon |
Prothrombin time shortened | Uncommon |
Pruritus | Common |
Pruritus generalized | Uncommon |
Pulmonary oedema | Not known |
Rales | Uncommon |
Rash erythematous | Uncommon |
Rash generalised | Uncommon |
Rash macular | Uncommon |
Rash morbilliform | Uncommon |
Rash pruritic | Uncommon |
Red blood cells urine positive | Uncommon |
Renal failure | Uncommon |
Sensation of heat (Feeling of warmth) (Sensation of warmth) | Uncommon |
Skin lesion | Uncommon |
Skin rash | Common |
Somnolence | Uncommon |
Stomach discomfort | Uncommon |
Swelling | Not known |
Tachycardia | Common |
Tachypnoea | Uncommon |
Tenderness | Uncommon |
Thrombocytopenia (Thrombopenia) | Uncommon |
Thrombophlebitis | Uncommon |
Tremor | Uncommon |
Urinary casts | Uncommon |
Urticaria | Uncommon |
Vision blurred | Uncommon |
Vomiting | Common |
Wheezing | Uncommon |
White blood cell count increased | Uncommon |
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Letocan 50mg MoH 2065154 :
Form | Powder for solution for injection |
Packaging | Bottle |
Package Size | Box of 1 |
Strength | 50mg |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✘ |
Submission date | 23/03/2021 |
Pending Year | 04/04/2022 |
Pending Reason | Incomplete file |
Price Comparison
You have to register to view this info
Drop File